Evidence map›Paper›PMID 39654042›Full record

ArticleBMC ophthalmology2024

Comparison of different treatment options in submacular haemorrhage.

Anna Hillenmayer, Christian M Wertheimer, Marlene Hillenmayer, Laura D Strehle, Lennart M Hartmann, Efstathios Vounotrypidis, Armin Wolf

Abstract readComparative Study
In one paragraph

Article in BMC ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anna HillenmayerDepartment of Ophthalmology, University of Ulm, Prittwitzstr. 43, 89075, Ulm, Germany. anna-hillenmayer@freenet.de.ORCID http://orcid.org/0000-0001-9433-3292
Christian M WertheimerDepartment of Ophthalmology, University of Ulm, Prittwitzstr. 43, 89075, Ulm, Germany.
Marlene HillenmayerDepartment of Ophthalmology, University of Ulm, Prittwitzstr. 43, 89075, Ulm, Germany.
Laura D StrehleDepartment of Ophthalmology, University of Ulm, Prittwitzstr. 43, 89075, Ulm, Germany.
Lennart M HartmannDepartment of Ophthalmology, University of Ulm, Prittwitzstr. 43, 89075, Ulm, Germany.
Efstathios VounotrypidisDepartment of Ophthalmology, University of Ulm, Prittwitzstr. 43, 89075, Ulm, Germany.
Armin WolfDepartment of Ophthalmology, University of Ulm, Prittwitzstr. 43, 89075, Ulm, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsSubmacular haemorrhages (SMH) cause significant visual impairment. Until now, the comparative effectiveness of different treatment approaches remains inconclusive without clear treatment guidelines. The aim of our study was to evaluate the effectiveness of 5 surgical treatment modalities in terms of visual prognosis and success rate.

methodsThis retrospective study included 201 patients with SMH. Primary endpoint was best corrected visual acuity (BCVA), secondary endpoints included haemorrhage size and complications. Group 1 was treated with pneumatic displacement and rtPA-injection. Group 2 followed the "Manchester protocol" with rtPA-injection and-if needed-a standardised secondary procedure with pars plana vitrectomy (ppV) and subretinal rtPA. Group 3 underwent vitrectomy with subretinal rtPA, group 4 vitrectomy only and group 5 received subretinal lavage.

resultsBaseline characteristics were a mean age of 79 years and a follow-up of 4.6 months. Pre-intervention BCVA of 1.7 logMAR improved to 1.4 logMAR at follow-up. A gain of > 0.2 logMAR was achieved in 47% of patients, while 20% lost > 0.2 logMAR. Only group 2 achieved a statistically significant visual gain. While group 5 was statistically larger in haemorrhage size preoperatively (p < 0.05), all groups were statistically equal in SMH size at follow-up. Complications led to additional interventions in 20% of patients.

conclusionsNo significant change in visual prognosis could be achieved depending on the intervention. As more invasive techniques seem to lack the benefit of a better postoperative prognosis while carrying higher risks, it may be beneficial considering a less invasive option first.

Indexed as

Retinal HemorrhageVisual AcuityVitrectomyAgedAged, 80 and overEndotamponadeFemaleFibrinolytic AgentsFollow-Up StudiesHumansMaleMiddle AgedRetrospective StudiesTissue Plasminogen ActivatorTomography, Optical CoherenceFibrinolytic AgentsTissue Plasminogen ActivatorMacular degenerationMacular haemorrhagePars plana vitrectomyPneumatic displacementRecombinant Plasminogen activatorRtPASubmacular haemorrhageSubretinal haemorrhageSubretinal lavage

Identifiers

PMID39654042
PMCPMC11626755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.